𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Weekly Oral Alendronic Acid in Male Osteoporosis

✍ Scribed by Dr Paul D. Miller, Thomas Schnitzer, Ronald Emkey, Eric Orwoll, Clifford Rosen, Mark Ettinger, Kristel Vandormael, Anastasia Daifotis

Book ID
119929922
Publisher
Springer International Publishing AG
Year
2004
Tongue
English
Weight
120 KB
Volume
24
Category
Article
ISSN
1179-1918

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and safety of a once-yearly i.v
Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study
✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; πŸ“‚ Article πŸ“… 2010 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi